FdaApplication
ANDA 208781
Identifiers
- fda_app_no: ANDA208781
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2022-04-26 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 150MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
5 products